Lion's Mane: What Actually Matters, From a Physician

Lion's mane is the supplement my patients ask me about most, and it's also the one with the most confusion attached to it. Half the marketing argues about mushrooms versus mycelium. The other half makes promises no mushroom can keep. Here's what the research actually supports, and what to ignore.

Two Parts of the Same Organism

Lion's mane (Hericium erinaceus) has two parts that end up in supplements: the fruiting body (the white mushroom you'd recognize) and the mycelium (the root-like network it grows from). They are not interchangeable, because they contain different active compounds.

The fruiting body is richer in compounds called hericenones. The mycelium is where you find erinacines — and erinacine A specifically is the most-studied member of that family. This is the whole reason the "mycelium vs. fruiting body" debate exists: they're chemically different source materials, and the compound with the most interesting neurological research, erinacine A, comes from the mycelium.

The fair criticism of mycelium products is that cheap ones are grown on grain and sold as "mycelium on grain," which dilutes the actual mycelium with starch. That's a real problem — but it's an argument for a standardized, grain-free mycelium, not against mycelium itself. The question to ask isn't "mushroom or mycelium." It's "how much of the active compound is actually in here, and can you prove it."

What erinacine A actually does — and where the evidence is strong vs. early

Here I have to be precise, because this is where marketing outruns science.

In laboratory and animal studies, erinacine A stimulates the synthesis of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) — proteins involved in the growth, maintenance, and survival of neurons (Lai et al., Int J Med Mushrooms, 2013). That mechanism is real and well-documented in the lab. It is not the same as saying a capsule does that in your brain at a given dose — crossing that gap in humans is exactly what's still being established, and any company claiming it's settled is ahead of the data.

In humans, the research is genuinely promising but earlier-stage:

- A small Japanese trial of older adults found lion's mane improved cognitive test scores over 16 weeks, with scores declining again after they stopped (Mori et al., Phytother Res, 2009).

- A 2024 pilot in healthy adults using an erinacine A-enriched mycelium reported improvements in cognitive processing speed and changes in BDNF (Cernelic Bizjak et al., J Funct Foods, 2024).

- A 49-week trial of an erinacine A-enriched mycelium in patients with mild Alzheimer's disease found it safe and reported signals on cognitive and biomarker measures (Li et al., Front Aging Neurosci, 2020, PMID 32581767). This was a study in a diagnosed patient population — not evidence that this or any supplement treats or prevents Alzheimer's or any disease.

What I tell patients: the mechanism is compelling, the early human signal points the right direction, and the honest word is supports — this is a long-game compound for maintaining cognitive function, not a drug and not an overnight effect. Anyone selling it as a cure for a diagnosed disease is making a claim the evidence doesn't support and the FDA doesn't allow.

The Number that Actually Matters

Erinacine A content is what separates a serious lion's mane product from mushroom powder in a capsule. Most products never disclose it. When you're comparing, look for:

1. Mycelium, if the goal is erinacine A — that's where the compound is.

2. A standardized erinacine A percentage, not just "lion's mane 1000 mg." A large dose of unstandardized powder can contain almost none.

3. Grain-free, so you're paying for mycelium, not filler starch.

4. A third-party certificate of analysis confirming identity and the erinacine A level for the actual batch.

If a label can't answer those four, the milligram number on the front is decoration.

Disclosure, and what I use

I should be direct about my stake: my husband, Kevin Palmer, is a chemist who formulates a cognitive line called NeuraLegend, and I'm its Chief Medical Officer — I review the formulas and I'm the one who signs off before anything ships. I'm naming it because it's the product built around exactly the four points above, and I'd rather disclose that than hide it.

Its lion's mane formula, NeuraLegend Core, is grain-free mycelium standardized to 1% erinacine A — 5 mg per serving — and the erinacine A lot testing is published. For context, 1% is a higher standard than the commonly published 0.5% material. It's one ingredient, disclosed and verified, which is the standard I'd want from anything I recommend.

This article is general health information, not medical advice. The research cited studied these ingredients, not any finished product, and these statements have not been evaluated by the FDA. Talk to your own clinician before starting a supplement.